Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
PR Newswire —
Tanabe Pharma America Remains Focused on Rare Disease Innovation and Addressing Unmet Patient Needs JERSEY CITY, N.J., April 1, 2026 /PRNewswire/ -- Tanabe Pharma America, Inc. (TPA), the wholly owned subsidiary of Tanabe Pharma Corporation, today announced the finalization of the...